Critical Care Pharmacology Flashcards

(38 cards)

1
Q

Vasoconstrictors

A

-Increases BP
-Increases afterload (some of them less than others)
-Constrict
-Limb ischemias can be affected
-can have more dysrrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inotropes

A

-Increases CO (contractility)
-Can cause more dysthymias
-Elevated lactates
-Can cause hotn/htn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vasodilators

A

-Decrease BP
-Dilate
-Decreases Afterload (some more than others)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Complications of vasodilators

A

-cerebral vasodilation and an increase in intracranial pressure (ICP)
-increased intrapulmonary shunt due to ablation of hypoxic pulmonary vasoconstriction, evidence of platelet dysfunction fromin vitrostudies,
-activation of the sympathetic nervous system with reflex tachycardia, rebound hypertension with discontinuation of its administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardiac Output

A

-Preload (filling)
-Contractility
-Afterload (resistance to systolic ejection)—effects with htn, valvular stenosis
-SV X HR = CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alpha 1

A

-Constriction on arteries and veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alpha 2

A

-Presynaptic terminal inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Beta 1

A

-Increased HR, conductivity, automacitity, contractility of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Beta 2

A

-Bronchodilation of lungs
-Dilation of arterioles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dopaminergic

A

-Vasodilation
-effects on the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Corticosteroids

A

-One of most controversial topics in management of sepsis
-Multiple studies have revealed there’s no benefit or harm
-Don’t need to do stim test just do it
-Rapidly wean over period of days
-When in doubt “stress em out”
-About a week, nice taper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vitamin C

A

-Cellular antioxidant
-Cofactor in catecholamine synthesis
-Catecholamine augmentation
-Acute Vit C deficiency common in sepsis
-Hydrocortisone-synergistic with vit c
-thiamine def-reduce hyper-oxalosis risk w/ high dose vit C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Epinephrine Action

A

-Action on a1, a2, b1, b2 agonist
-1-3mcg/min=B
-3-10 mcg/min=B and a
-10+mcg= a and B
-Increase the HR more as dose increases
-Considered an inotrope = increased contractlity most significantly
-Increases preload
-At 10+ mcg/min will increase SVR & PVR otherwise doesn’t not have much affect on SVR at lower doses
-Increases BP
-Increases CO at lower doses, 10+ mcg/min will decrease CO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Indications for Epinephrine

A

-Cardiac Arrest
-Anaphylaxis
-Cardiogenic shock
-Bronchospasm
-Reduced CO
-Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopamine Indications

A

-Low CO
-Low SVR
-Renal insufficiency?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dopamine Action

A

-α1, β1, β2, D1 agonist
-Indirect NE release
-1-3μg/kg/min = D1
-3-10 = β1,β2>D1
-10+ = α1>β, D
-Will increase HR at larger doses
-Increases contractality more with increased doses
-Increases preload
-Higher doses will increase SVR and PVR
-CO will increase as well as BP
-2-20 mcg/kg/min infusion

17
Q

Dobutamine Indications

A

-Low CO (esp with ↑SVR)
-Right heart failure
-Stress Echocardiography

18
Q

Dobutamine Action

A

-Strong β1> β2
-Weak α1
-Increases HR and Contractility and CO
-No affect with preload
-Could increase SVR & PVR in B-blocked patients
-BP varies (generally increases)
- 2-30 mcg/kg/min (never seen it >6mcg/kg/min) infusion
-Considered iontrope

19
Q

Milrinone Indications

A

-Low CO (esp with ↑SVR)
-Right heart failure
-Pulm HTN
-Supplement β-agonists
-Reduced proarrhythmic effect

20
Q

Milrinone Action

A

-Inhibits Phosphodiesterase III
-Increases cAMP
-Doesn’t act at β receptors
-Increased contractility
-Decreased PVR/SVR
-Increases contractility & CO
-Lowers preload
-Varies with Bp
-0.375-0.75mcg/kg/min

21
Q

Ca Chloride/Gluconate

A

-Action: Free Ca Ion
-Increases contractility, SVR/PVR
-Indications: Hypocalcemia, hypokalemia, hotn from hypocalcemia, CCB, or protamine, anesthetic overdose, counter act hypermagnesemia
-1-2g IVP

22
Q

Phenylephrine Indications

A

-Peripheral vasodilation
-Low SVR
-SVT (Reflex vagal stim)
-TET spell
-10-150 mcg/min

23
Q

Phenylephrine Action

A

-A1 agonist
-Reflex tachycardia
-No difference on contractility, preload and indifference with CO
-Increases SVR/PVR, BP
-10mg/10mL or 100mcg/1mL in codes

24
Q

Norepinephrine Action

A

-α1, α2, β1 agonist
-Intense α1 and α2 constriction throughout dosing range
-Variable affect on HR
-Increases contractility, preload, SVR/PVR, BP and medium to CO

25
Norepinephrine Indications
-Peripheral vascular collapse -Shock, vasoplegia -↓SVR -Need ↑SVR with some ↑Con -Phenylephrine isn’t working -2-20 mcg/min some come in mcg/kg/min
26
Vasopressin Action
-Direct vasoconstriction via V1 receptors -No action on β or α receptors -No affect on HR, Contractility, preload -Variable with CO -Increases BP -Increases SVR, decreases PVR?
27
Vasopressin Indication
-Alt to Epi in Cardiac arrest -Secondline agent: Shock, vasoplegia, sepsis, ↓SVR -Pulm HTN with ↓SVR? -Physiologic dose with Milrinone -To reduce Norepi dose -0.01-0.06U/min -Bolus 40U IV for VF arrest
28
Methylene Blue Action
-Complex mechanism -Inhibits NO/cGMP -Inhibits NO synthase -Increases SVR/PVR -Increases BP -Not first line -Bolus 1.5-2.0mg/kg over 15-30 min -Infusion 0.25-1.0 mg/kg/hr
29
Nitroglycerin Action
-Direct vasodilator ↑cGMP production -Venous>Arterial -Excellent coronary effects -Reflex contractility and HR -Decreases Preload (don't give to inferior MIs) -Decreases SVR/PVR -Decreases BP
30
Nitroglycerin Indication
-Myocardial ischemia -Increase coronary perfusion -Relieve coronary spasm -Hypertension -Arterial dilation (high dose) -Pulmonary HTN -CHF -40-80 mg IV bolus -10-200 mcg/min infusion
31
Nitroprusside Action
-Direct vasodilator ↑cGMP production -Arterial=Venous -Reflex effect on HR and Contractility -Decreases preload, SVR/PVR, BP
32
Nitroprusside Indications
HTN, ↑SVR Controlled hypotension ↓SVR>↓Preload at lower dose -0.1-2.0mcg/kg/min infusion -Avoid >2.0 d/t toxicity -protect from light -use with caution in liver and kidney disease -Taper infusion gradually
33
Clevidipine Action
-CCB vasodilator -No affect on HR, contractility -Decreases preload, SVR/PVR
34
Clevidipine Indications
HTN, ↑SVR Controlled hypotension ↓SVR>↓Preload at lower dose -Maintenance: 4-6 mg/hr; not to exceed 21 mg/hr (1000 mL within 24 hour period)
35
Angiotensin II
-Effective in increases MAP -Adverse effect monitoring -Dosing and duration limitation (be careful on running too long)
36
Hydrococolbalmin (Cyanokit)
-Hydroxylated, active form of vitamin B12 -Nitric oxide scavenger -FDA approval: treatment of Cyanide poisoning 5 g in 200 mL 0.9% NaCl -Infusion over 15 minutes or 6 hours -Suggestive data for utility in refractory vasoplegia -Remains in bloodstream and urine days to weeks -Interferes with labs and urinalysis
37
Alpha 1 Agonists
-Mainly present in smooth muscle of blood vessels and muscle tissues of the heart -Cause blood vessels to constrict
38
Shock Management
-Treat underlying cause -Fluid Resuscitation -Vasopressor monotherapy >> -Treat w/ contributing pathophysiology -Combo vasopressor -Trial steroids, and adjunctive agents (thiamine, vit c) -Novel vasopressor therapy (Angiotensin II) -Rescue therapies (Methylene blue, cyanokit)